Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06451263
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-14
First Post:
2024-05-31
Brief Title:
Nudge to Gynecologic Oncology
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Abramson Cancer Center at Penn Medicine
Study Overview
Official Title:
Nudge to Referral of Adnexal Masses to Gynecologic Oncology
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Ovarian cancer lacks an effective screening test and prompt treatment at diagnosis is the only way to improve outcomes Referral to gynecologic oncology at diagnosis of adnexal mass is recommend by guidelines from every major medical organization Yet 1 in 4 patients with ovarian cancer nationwide and at Penn Medicine never see a gynecologic oncologist Even when referred to gynecologic oncology patients from historically-marginalized groups have twice as long duration from diagnosis to seeing gynecologic oncology In this project the investigators will pilot a clinician nudge to gynecologic oncology referral and compare the impact to historical controls
Detailed Description:
The study consists of one intervention a clinician nudge to gynecologic oncology referral Referral to gynecologic oncology is recommended when patients are diagnosed with a complex adnexal mass on imaging ie Ovarian-Adnexal Reporting and Data System O-RADS 4 or 5 on ultrasound or Magnetic Resonance Imaging MRI When patients are identified as having a complex adnexal mass the order will be pended by the clinical research coordinator and sent to the ordering provider with a message to sign The message will include content about national guidelines on referral to gynecologic oncology with opt-out framed language
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None